Cargando…
Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis
BACKGROUND: Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only. Thus, there is a knowledge gap regarding its application during infectious diarrhea...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383374/ https://www.ncbi.nlm.nih.gov/pubmed/34429170 http://dx.doi.org/10.1186/s40813-021-00228-9 |
_version_ | 1783741725149233152 |
---|---|
author | Barbosa, Jéssica A. Rodrigues, Lucas A. Columbus, Daniel A. Aguirre, Juan C. P. Harding, John C. S. Cantarelli, Vinícius S. Costa, Matheus de O. |
author_facet | Barbosa, Jéssica A. Rodrigues, Lucas A. Columbus, Daniel A. Aguirre, Juan C. P. Harding, John C. S. Cantarelli, Vinícius S. Costa, Matheus de O. |
author_sort | Barbosa, Jéssica A. |
collection | PubMed |
description | BACKGROUND: Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only. Thus, there is a knowledge gap regarding its application during infectious diarrhea. This study investigated the usefulness of fecal calprotectin as a biomarker of intestinal inflammation in Brachyspira hyodysenteriae and Salmonella Typhimurium infected pigs. RESULTS: Fecal samples from pigs with colitis (n = 18) were collected from animals experimentally inoculated with B. hyodysenteriae (n = 8) or from sham-inoculated controls (n = 3). Fecal samples from pigs with enteritis (n = 14) were collected from animals inoculated with Salmonella enterica serovar Typhimurium (n = 8) or from sham-inoculated controls (n = 4). For both groups, fecal samples were scored as: 0 = normal; 1 = soft, wet cement; 2 = watery feces; 3 = mucoid diarrhea; and 4 = bloody diarrhea. Fecal calprotectin levels were assayed using a sandwich ELISA, a turbidimetric immunoassay and a point-of-care dipstick test. Fecal calprotectin levels were greater in colitis samples scoring 4 versus ≤ 4 using ELISA, and in feces scoring 3 and 4 versus ≤ 1 using immunoturbidimetry (P < 0.05). No differences were found in calprotectin concentration among fecal scores for enteritis samples, regardless of the assay used. All samples were found below detection limits using the dipstick method. CONCLUSIONS: Fecal calprotectin levels are increased following the development of colitis, but do not significantly change due to enteritis. While practical, the use of commercially available human kits present sensitivity limitations. Further studies are needed to validate the field application of calprotectin as a marker of intestinal inflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40813-021-00228-9. |
format | Online Article Text |
id | pubmed-8383374 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83833742021-08-25 Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis Barbosa, Jéssica A. Rodrigues, Lucas A. Columbus, Daniel A. Aguirre, Juan C. P. Harding, John C. S. Cantarelli, Vinícius S. Costa, Matheus de O. Porcine Health Manag Research BACKGROUND: Fecal calprotectin is largely applied as a non-invasive intestinal inflammation biomarker in human medicine. Previous studies in pigs investigated the levels of fecal calprotectin in healthy animals only. Thus, there is a knowledge gap regarding its application during infectious diarrhea. This study investigated the usefulness of fecal calprotectin as a biomarker of intestinal inflammation in Brachyspira hyodysenteriae and Salmonella Typhimurium infected pigs. RESULTS: Fecal samples from pigs with colitis (n = 18) were collected from animals experimentally inoculated with B. hyodysenteriae (n = 8) or from sham-inoculated controls (n = 3). Fecal samples from pigs with enteritis (n = 14) were collected from animals inoculated with Salmonella enterica serovar Typhimurium (n = 8) or from sham-inoculated controls (n = 4). For both groups, fecal samples were scored as: 0 = normal; 1 = soft, wet cement; 2 = watery feces; 3 = mucoid diarrhea; and 4 = bloody diarrhea. Fecal calprotectin levels were assayed using a sandwich ELISA, a turbidimetric immunoassay and a point-of-care dipstick test. Fecal calprotectin levels were greater in colitis samples scoring 4 versus ≤ 4 using ELISA, and in feces scoring 3 and 4 versus ≤ 1 using immunoturbidimetry (P < 0.05). No differences were found in calprotectin concentration among fecal scores for enteritis samples, regardless of the assay used. All samples were found below detection limits using the dipstick method. CONCLUSIONS: Fecal calprotectin levels are increased following the development of colitis, but do not significantly change due to enteritis. While practical, the use of commercially available human kits present sensitivity limitations. Further studies are needed to validate the field application of calprotectin as a marker of intestinal inflammation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40813-021-00228-9. BioMed Central 2021-08-24 /pmc/articles/PMC8383374/ /pubmed/34429170 http://dx.doi.org/10.1186/s40813-021-00228-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Barbosa, Jéssica A. Rodrigues, Lucas A. Columbus, Daniel A. Aguirre, Juan C. P. Harding, John C. S. Cantarelli, Vinícius S. Costa, Matheus de O. Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis |
title | Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis |
title_full | Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis |
title_fullStr | Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis |
title_full_unstemmed | Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis |
title_short | Experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis |
title_sort | experimental infectious challenge in pigs leads to elevated fecal calprotectin levels following colitis, but not enteritis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383374/ https://www.ncbi.nlm.nih.gov/pubmed/34429170 http://dx.doi.org/10.1186/s40813-021-00228-9 |
work_keys_str_mv | AT barbosajessicaa experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis AT rodrigueslucasa experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis AT columbusdaniela experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis AT aguirrejuancp experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis AT hardingjohncs experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis AT cantarelliviniciuss experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis AT costamatheusdeo experimentalinfectiouschallengeinpigsleadstoelevatedfecalcalprotectinlevelsfollowingcolitisbutnotenteritis |